Tech Journal of Mauritius
SEE OTHER BRANDS

Exploring the science and technology news of Mauritius

Tech Journal of Mauritius: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Mauritius.

Press releases published on October 22, 2025

Onco3R Therapeutics reports first pre-clinical data from its best-in-class precision oncology portfolio at the 2025 AACR-NCI-EORTC symposium
17a-4 offers eDisclaimer and WebParser Bundle for End-of-Year Savings
Elevara Medicines Raises $70 Million Series A to Advance  Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline
Datavault AI Menunjuk Veteran Angkatan Laut AS Pete Scobell sebagai Wakil Presiden, Keamanan Global
データボルトAI (Datavault AI)、米海軍退役軍人ピート・スコベル (Pete Scobell) をグローバルセキュリティ担当副社長に任命
Datavault AI, 전 미 해군 네이비실 출신 피트 스코벨(Pete Scobell)을 글로벌 보안 부문 부사장으로 임명
Datavault AI Melantik Veteran Tentera Laut AS Pete Scobell sebagai Naib Presiden Keselamatan Global
Datavault AI แต่งตั้งอดีตทหารผ่านศึกกองทัพเรือสหรัฐฯ Pete Scobell…
Datavault AI 任命美国海军退伍军人 Pete Scobell 为公司全球安全事务副总裁
Datavault AI 委任美國海軍退伍軍人 Pete Scobell 為全球安全副總裁
Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
Ipsen enregistre une forte dynamique commerciale au cours des neuf premiers mois de l'année 2025 et revoit à la hausse ses prévisions pour l'exercice en cours
Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study
Communiqué de presse : L’efdoralprine alfa de Sanofi a atteint tous les critères d’évaluation principaux et secondaires clés dans l’étude de phase II sur l’emphysème par déficit en alpha-1-antitrypsine
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
Ipsen annonce son intention d’acquérir ImCheck Therapeutics et étend son leadership en oncologie avec un portefeuille enrichi de produits en R&D
ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Development of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
Safer Roads, Smarter Fleets: Geotab & Vitality Launch Data-Driven Behavioural Science Joint Venture

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions